RYR1 and metabolic dysfunction-associated steatohepatitis: The 9 RYR1 mutations identified in mouse and human NASH-HCCs were located across the whole gene, with 3 stop-gain or truncating mutations inferring likely loss-of-function mutations (Fig. 7d).